BHP Billiton Limited vs Bio-Rad Laboratories, Inc. Class A Common Stock — how do they compare? BHP Billiton Limited trades at $90.9 (market cap $229.15B), while Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B). The key difference: BHP Billiton Limited is far larger — about 24.3× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and BHP Billiton Limited pays a 2.95% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BHP | BIO | |
|---|---|---|
Market Cap | $229.15B | $9.43B |
Sector | Basic Materials | Health |
52-Week High | $93.15 | $356.25 |
52-Week Low | $52.14 | $241.71 |
Enterprise Value | $243.35B | $9.18B |
Dividend Yield | 2.95% | — |
Trailing returns across standard periods
BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →